Anti-Human TNFRSF10A Therapeutic Antibody (4E7.24.3)

The antibody binds to DR4, but not to any of the other Apo-2L receptors, Apo-2, DcRl, or DcR2. It can be potentially used in the treatment of various diseases and pathological conditions, including cancer.
Supplier Creative Biolabs
Product # TAB-162CQ
Pricing Inquiry
Applications FC, ELISA, Block
Host Mouse
Target DR4 (Death receptor 4)
Species Reactivity Human
Feedback